Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 5
Number of items: 5
  • Open Access
    Douma, E. H., Smidt, M. P., & van der Heide, L. P. (2024). Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson's disease. Trends in Molecular Medicine, 30(9), 800-803. https://doi.org/10.1016/j.molmed.2024.06.002
  • Open Access
    Douma, E. H., Stoop, J., Lingl, M. V. R., Smidt, M. P., & van der Heide, L. P. (2024). Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits. Cell and Bioscience, 14, Article 132. https://doi.org/10.1186/s13578-024-01312-7
  • Open Access
    Stoop, J., Douma, E. H., van der Vlag, M., Smidt, M. P., & van der Heide, L. P. (2023). Tyrosine hydroxylase phosphorylation is under the control of serine 40. Journal of neurochemistry, 167(3), 376-393. https://doi.org/10.1111/jnc.15963
  • Open Access
    Douma, E. H. (2023). Replenishing dopamine in Parkinson’s disease: Tyrosine hydroxylase Ser40 phosphorylation and phosphodiesterase inhibition. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Douma, E. H., & de Kloet, E. R. (2020). Stress-induced plasticity and functioning of ventral tegmental dopamine neurons. Neuroscience and Biobehavioral Reviews, 108, 48-77. https://doi.org/10.1016/j.neubiorev.2019.10.015
Page of